The items in this document are provided ... - sbigroup.co.jp · In addition, IQ FY2013 is expected...

15

Transcript of The items in this document are provided ... - sbigroup.co.jp · In addition, IQ FY2013 is expected...

Page 1: The items in this document are provided ... - sbigroup.co.jp · In addition, IQ FY2013 is expected to include valuation gains based on fair value for the IPO of ReproCELL. *2 For
Page 2: The items in this document are provided ... - sbigroup.co.jp · In addition, IQ FY2013 is expected to include valuation gains based on fair value for the IPO of ReproCELL. *2 For

The items in this document are provided as information related to the financial results and the business strategy of the SBI Group companies and not as an invitation to invest in the stock or securities issued by each company.

None of the Group companies guarantees the completeness of this document in terms of information and future business strategy.

The content of this document is subject to revision or cancellation without warning.

Note: Fiscal Year (“FY”) ends Mar. 31 of the following year

Page 3: The items in this document are provided ... - sbigroup.co.jp · In addition, IQ FY2013 is expected to include valuation gains based on fair value for the IPO of ReproCELL. *2 For
Page 4: The items in this document are provided ... - sbigroup.co.jp · In addition, IQ FY2013 is expected to include valuation gains based on fair value for the IPO of ReproCELL. *2 For
Page 5: The items in this document are provided ... - sbigroup.co.jp · In addition, IQ FY2013 is expected to include valuation gains based on fair value for the IPO of ReproCELL. *2 For
Page 6: The items in this document are provided ... - sbigroup.co.jp · In addition, IQ FY2013 is expected to include valuation gains based on fair value for the IPO of ReproCELL. *2 For

6

2. What is ReproCELL's IPO effect on the performance?

Page 7: The items in this document are provided ... - sbigroup.co.jp · In addition, IQ FY2013 is expected to include valuation gains based on fair value for the IPO of ReproCELL. *2 For
Page 8: The items in this document are provided ... - sbigroup.co.jp · In addition, IQ FY2013 is expected to include valuation gains based on fair value for the IPO of ReproCELL. *2 For
Page 9: The items in this document are provided ... - sbigroup.co.jp · In addition, IQ FY2013 is expected to include valuation gains based on fair value for the IPO of ReproCELL. *2 For
Page 10: The items in this document are provided ... - sbigroup.co.jp · In addition, IQ FY2013 is expected to include valuation gains based on fair value for the IPO of ReproCELL. *2 For
Page 11: The items in this document are provided ... - sbigroup.co.jp · In addition, IQ FY2013 is expected to include valuation gains based on fair value for the IPO of ReproCELL. *2 For
Page 12: The items in this document are provided ... - sbigroup.co.jp · In addition, IQ FY2013 is expected to include valuation gains based on fair value for the IPO of ReproCELL. *2 For
Page 13: The items in this document are provided ... - sbigroup.co.jp · In addition, IQ FY2013 is expected to include valuation gains based on fair value for the IPO of ReproCELL. *2 For
Page 14: The items in this document are provided ... - sbigroup.co.jp · In addition, IQ FY2013 is expected to include valuation gains based on fair value for the IPO of ReproCELL. *2 For
Page 15: The items in this document are provided ... - sbigroup.co.jp · In addition, IQ FY2013 is expected to include valuation gains based on fair value for the IPO of ReproCELL. *2 For